RCUS
Arcus Biosciences Inc.
$22.65
+$0.57(+2.61%)
42
Overall
60
Value
20
Tech
47
Quality
Market Cap
$2.77B
Volume
462.24K
52W Range
$6.50 - $26.40
Target Price
$34.20
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $8.4M | $15.0M | $77.5M | $383.0M | $112.0M | $117.0M | $258.0M | ||
| Total Revenue | $8.4M | $15.0M | $77.5M | $383.0M | $112.0M | $117.0M | $258.0M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $8.4M | $15.0M | $77.5M | $383.0M | $112.0M | $117.0M | $258.0M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $63.2M | $103.7M | $201.8M | $329.0M | $392.0M | $457.0M | $588.0M | ||
| Research & Development | $49.6M | $78.5M | $159.3M | $257.0M | $288.0M | $340.0M | $448.0M | ||
| Research Expense | $49.6M | $78.5M | $159.3M | $257.0M | $288.0M | $340.0M | $448.0M | ||
| Selling, General & Administrative | $13.6M | $25.2M | $42.4M | $72.0M | $104.0M | $117.0M | $120.0M | ||
| General & Administrative Expenses | $13.6M | $25.2M | $42.4M | $72.0M | $104.0M | $117.0M | $120.0M | ||
| OPERATING INCOME | |||||||||
| Operating income | $-54.9M | $-88.7M | $-124.2M | $54.0M | $-280.0M | $-340.0M | $-330.0M | ||
| EBITDA | $-45.9M | $-81.1M | $-118.7M | $62.0M | $-252.0M | $-283.0M | $-261.0M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | $2.0M | $4.0M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | -- | -- | -- | $-2.0M | $-4.0M | ||
| Gain on Sale of Securities | -- | -- | $613.0K | -- | -- | -- | -- | ||
| Other Income/Expense | $-343.0K | $1.2M | -- | -- | -- | $-80.0M | $20.0M | ||
| Other Special Charges | -- | -- | -- | -- | -- | $80.0M | $207.0M | ||
| SPECIAL ITEMS | |||||||||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $20.0M | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-49.6M | $-84.7M | $-122.9M | $55.0M | $-266.0M | $-299.0M | $-278.0M | ||
| Pre-Tax Income | $-54.5M | $-89.9M | $-122.9M | $55.0M | $-266.0M | $-301.0M | $-282.0M | ||
| INCOME TAX | |||||||||
| Tax Provision | -- | -- | -- | $2.0M | $1.0M | $6.0M | $1.0M | ||
| NET INCOME | |||||||||
| Net Income | $-49.6M | $-84.7M | $-122.9M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
| Net Income (Continuing Operations) | $-49.6M | $-84.7M | $-122.9M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
| Net Income (Discontinued Operations) | $-49.6M | $-84.7M | $-122.9M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
| Net Income (Common Stockholders) | $-49.6M | $-84.7M | $-122.9M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
| Normalized Income | $-43.1M | $-71.0M | $-97.1M | $43.5M | $-210.1M | $-237.8M | $-259.2M | ||
| TOTALS | |||||||||
| Total Expenses | $63.2M | $103.7M | $201.8M | $329.0M | $392.0M | $457.0M | $588.0M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $34.6M | $43.8M | $54.8M | $69.3M | $72.0M | $74.0M | $90.1M | ||
| Average Shares Outstanding (Diluted) | $34.6M | $43.8M | $54.8M | $74.0M | $72.0M | $74.0M | $90.1M | ||
| Shares Outstanding | $44.5M | $46.0M | $70.9M | $71.1M | $73.0M | $90.9M | $105.8M | ||
| Basic EPS | $-1.43 | $-1.93 | $-2.24 | $0.76 | $-3.71 | $-4.15 | $-3.14 | ||
| Basic EPS (Continuing Operations) | $-1.43 | $-1.93 | $-2.24 | $0.76 | $-3.71 | $-4.15 | $-3.14 | ||
| Diluted EPS | $-1.43 | $-1.93 | $-2.24 | $0.71 | $-3.71 | $-4.15 | $-3.14 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $0.71 | $-3.71 | $-4.15 | $-3.14 | ||
| OTHER METRICS | |||||||||
| Earnings from equity interest | $343.0K | $-1.2M | $-613.0K | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $343.0K | $-1.2M | $-613.0K | -- | -- | -- | -- | ||
| Other Gand A | $13.6M | $25.2M | $42.4M | $72.0M | $104.0M | $117.0M | $120.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCUS | $22.65 | +2.6% | 462.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |